Erratum Statement on our communication to French customers dated June 14, 2024, relating to the new European authorization of Hy-D®
15 Jul 2024
During our French communication of June 14 to our customers in France with regards to the regulatory news relating to the new European authorization of Hy-D®, a wording error was made in the last paragraph and we would like to correct this error.. In that communication, it was mistakenly mentioned that the European Commission had banned "the simultaneous use of 25-hydroxycholecalciferol and calcitriol (1,25(OH)2D3) from Solanum glaucophyllum". Indeed, the regulation in question does not refer to Solanum glaucophyllum itself, but explicitly to the extract of Solanum glaucophyllum.